Sichuan Hebang Biotechnology Stock Hits Day Low Amid Price Pressure at CNY 2.07

Sichuan Hebang Biotechnology Co., Ltd. experienced a notable decline today, with the stock dropping by 3.7% and reaching an intraday low of CNY 2.07. This performance contrasts with the China Shanghai Composite, which fell by 2.06% on the same day. Over the past week, Sichuan Hebang's stock has decreased by 10.73%, and its monthly performance shows a decline of 14.05%. Despite a year-over-year increase of 14.29%, the company has faced significant challenges, reflected in its year-to-date performance of -7.96%. Over the last three years, the stock has decreased by 15.1%, and over the past decade, it has seen a substantial drop of 58.4%. Financial metrics indicate that the company has struggled with profitability, reporting negative results for the last ten consecutive quarters. Net sales for the first half of the year were CNY 4,177.1 million, down 13.24%, while net profit showed a significant decline of 57.92%. The company's market capitalization stands at CNY 20,224 million, and it operates within the Chemicals & Petrochemicals industry.